Best-selling CBD brand Medterra was founded by a handful of individuals with tremendous passion about the power of cannabidiol-infused products. Furthermore, Medterra believes that CBD should be available to all those in need at an affordable price. Currently offering CBD oil tinctures, CBD-infused gummies, CBD creams and topicals, CBD supplements, and more, Medterra offers high-quality products for every type of consumer – even cats and dogs.
As a result of Medterra’s rapid growth and success, a lot of investors have asked us – ‘is Medterra publicly traded?‘ and ‘can you buy stock in Medterra?‘
Is Medterra Publicly Traded?
There are hundreds of marijuana and hemp stocks listed across the NASDAQ, NYSE, TSX, CSE, OTC markets and other exchanges, but unfortunately Medterra is not one of them – at the moment.
Given the company’s success, it would not be surprising if Medterra decided to IPO or go public via reverse merger. That said, it also would not be a shocker if Medterra were to be strategically acquired by a much larger cannabis-related or supplements/nutraceuticals company with an interest in bringing the brand into their umbrella.
Who Owns Medterra?
That answer does lead many to question who does own Medterra, if not the public?
According to the Medterra website, “Medterra CBD, LLC” is the entity that operates the e-store. USPTO filings show that Medterra CBD, LLC is also the owner of multiple trademarks.
According to a previous press release from the company, the parent company may be called “Medterra CBD Inc.”
Conclusion
Given Medterra’s rapid growth within the CBD space, it would not be surprising if Medterra decided to IPO or go public via reverse merger. That being said, it also would not be a big surprise if Medterra were to be acquired by a much larger company with an interest in bringing the brand into their umbrella.
Get Real-Time Updates from MJobserver.com
